IL-17A, a possible biomarker for the evaluation of treatment response in Trypanosoma cruzi infected children: A 12-months follow-up study in Bolivia.

IL-17A, a possible biomarker for the evaluation of treatment response in Trypanosoma cruzi infected children: A 12-months follow-up study in Bolivia.

BACKGROUND:The National Program for Chagas disease was implemented in Bolivia in 2006, and it greatly decreased the number of infections through vector control. Subsequently, a treatment regimen of benznidazole (BNZ) was started in seropositive school-age children living in certified vector control...

Full description

Bibliographic Details
Main Authors: Clara Vásquez Velásquez, Graciela Russomando, Emilio E Espínola, Zunilda Sanchez, Kota Mochizuki, Yelin Roca, Jimmy Revollo, Angelica Guzman, Benjamín Quiroga, Susana Rios Morgan, Roberto Vargas Ortiz, Alberto Zambrana Ortega, Eida Espinoza, Juan Eiki Nishizawa, Mohamed Gomaa Kamel, Mihoko Kikuchi, Shusaku Mizukami, Kesara Na-Bangchang, Nguyen Tien Huy, Kenji Hirayama
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-09-01
Series:PLoS Neglected Tropical Diseases
Online Access:https://doi.org/10.1371/journal.pntd.0007715

Internet

https://doi.org/10.1371/journal.pntd.0007715

Similar Items